Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 34

References for PMC Articles for PubMed (Select 20141240)

1.

Distinct neural generators of sensory gating in schizophrenia.

Williams TJ, Nuechterlein KH, Subotnik KL, Yee CM.

Psychophysiology. 2011 Apr;48(4):470-8. doi: 10.1111/j.1469-8986.2010.01119.x. Epub 2010 Aug 23.

2.

Sensory gating in schizophrenia: P50 and N100 gating in antipsychotic-free subjects at risk, first-episode, and chronic patients.

Brockhaus-Dumke A, Schultze-Lutter F, Mueller R, Tendolkar I, Bechdolf A, Pukrop R, Klosterkoetter J, Ruhrmann S.

Biol Psychiatry. 2008 Sep 1;64(5):376-84. doi: 10.1016/j.biopsych.2008.02.006. Epub 2008 Apr 8.

PMID:
18395700
3.

P50 sensory gating ratios in schizophrenics and controls: a review and data analysis.

Patterson JV, Hetrick WP, Boutros NN, Jin Y, Sandman C, Stern H, Potkin S, Bunney WE Jr.

Psychiatry Res. 2008 Mar 15;158(2):226-47. doi: 10.1016/j.psychres.2007.02.009. Epub 2008 Jan 9. Review.

PMID:
18187207
4.

Impaired top-down control of visual search in schizophrenia.

Gold JM, Fuller RL, Robinson BM, Braun EL, Luck SJ.

Schizophr Res. 2007 Aug;94(1-3):148-55. Epub 2007 Jun 4.

5.

Increased hemodynamic response in the hippocampus, thalamus and prefrontal cortex during abnormal sensory gating in schizophrenia.

Tregellas JR, Davalos DB, Rojas DC, Waldo MC, Gibson L, Wylie K, Du YP, Freedman R.

Schizophr Res. 2007 May;92(1-3):262-72. Epub 2007 Mar 2.

6.

Visual attention circuitry in schizophrenia investigated with oddball event-related functional magnetic resonance imaging.

Gur RE, Turetsky BI, Loughead J, Snyder W, Kohler C, Elliott M, Pratiwadi R, Ragland JD, Bilker WB, Siegel SJ, Kanes SJ, Arnold SE, Gur RC.

Am J Psychiatry. 2007 Mar;164(3):442-9.

PMID:
17329469
7.

P50 sensitivity to physical and psychological state influences.

White PM, Yee CM.

Psychophysiology. 2006 May;43(3):320-8.

PMID:
16805872
8.

Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia.

Olincy A, Harris JG, Johnson LL, Pender V, Kongs S, Allensworth D, Ellis J, Zerbe GO, Leonard S, Stevens KE, Stevens JO, Martin L, Adler LE, Soti F, Kem WR, Freedman R.

Arch Gen Psychiatry. 2006 Jun;63(6):630-8.

PMID:
16754836
9.

Varied effects of atypical neuroleptics on P50 auditory gating in schizophrenia patients.

Adler LE, Olincy A, Cawthra EM, McRae KA, Harris JG, Nagamoto HT, Waldo MC, Hall MH, Bowles A, Woodward L, Ross RG, Freedman R.

Am J Psychiatry. 2004 Oct;161(10):1822-8.

PMID:
15465979
10.

Meta-analysis of the P300 and P50 waveforms in schizophrenia.

Bramon E, Rabe-Hesketh S, Sham P, Murray RM, Frangou S.

Schizophr Res. 2004 Oct 1;70(2-3):315-29.

PMID:
15329307
11.

Selective attention in schizophrenia: sparing and loss of executive control.

Mathalon DH, Heinks T, Ford JM.

Am J Psychiatry. 2004 May;161(5):872-81.

PMID:
15121653
12.

Preattentional and attentional cognitive deficits as targets for treating schizophrenia.

Braff DL, Light GA.

Psychopharmacology (Berl). 2004 Jun;174(1):75-85. Epub 2004 Apr 30.

PMID:
15118804
13.

Disorders of attention and perception in early schizophrenia.

MCGHIE A, CHAPMAN J.

Br J Med Psychol. 1961;34:103-16. No abstract available.

PMID:
13773940
14.

Experimental modification of P50 suppression.

Yee CM, White PM.

Psychophysiology. 2001 May;38(3):531-9.

PMID:
11352142
15.

Inhibitory neurophysiological deficit as a phenotype for genetic investigation of schizophrenia.

Freedman R, Adams CE, Adler LE, Bickford PC, Gault J, Harris JG, Nagamoto HT, Olincy A, Ross RG, Stevens KE, Waldo M, Leonard S.

Am J Med Genet. 2000 Spring;97(1):58-64. Review.

PMID:
10813805
16.

Normal P50 suppression in schizophrenia patients treated with atypical antipsychotic medications.

Light GA, Geyer MA, Clementz BA, Cadenhead KS, Braff DL.

Am J Psychiatry. 2000 May;157(5):767-71.

PMID:
10784470
17.

P50 suppression in recent-onset schizophrenia: clinical correlates and risperidone effects.

Yee CM, Nuechterlein KH, Morris SE, White PM.

J Abnorm Psychol. 1998 Nov;107(4):691-8.

PMID:
9830258
18.

P50 abnormalities in schizophrenia: relationship to clinical and neuropsychological indices of attention.

Erwin RJ, Turetsky BI, Moberg P, Gur RC, Gur RE.

Schizophr Res. 1998 Oct 9;33(3):157-67.

PMID:
9789908
19.

Sensory gain control (amplification) as a mechanism of selective attention: electrophysiological and neuroimaging evidence.

Hillyard SA, Vogel EK, Luck SJ.

Philos Trans R Soc Lond B Biol Sci. 1998 Aug 29;353(1373):1257-70.

20.

Training and quality assurance with the Structured Clinical Interview for DSM-IV (SCID-I/P).

Ventura J, Liberman RP, Green MF, Shaner A, Mintz J.

Psychiatry Res. 1998 Jun 15;79(2):163-73.

PMID:
9705054
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk